Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors

NCT05189054 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05189054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05189054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of SBRT in the Reirradiation for Ultra-central Thoracic Malignant Tumors
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2022
Completion date
April 30, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irradiation; reaction, recurrent cancer, stereotactic body radiation therapy, thoracic tumor